Document Detail


Primary peritoneal spindle cell sarcoma presented with massive ascites: a case report.
MedLine Citation:
PMID:  20148470     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Soft tissue sarcomas (STSs) are a heterogeneous group of rare neoplasms originating from the embryonic mesoderm and mesenchymal cells. Primary peritoneal sarcomas have been reported as leiomyosarcoma, liposarcoma and carcinosarcoma. However, primary peritoneal spindle cell sarcoma has never been reported in the literature. Herein, we report on a 38-year-old woman with massive ascites diagnosed as primary peritoneal spindle cell sarcoma. Following doxorubicin and ifosfamide chemotherapy, her symptoms improved and ascites regressed. Other primary peritoneal sarcomas rarely cause massive ascites. We suggest that in patients presenting with massive exudative ascites associated with malignancy, primary peritoneal sarcomas should be also considered in the differential diagnosis.
Authors:
A Bilici; K Uygun; E Altun; E Karci; Y Gurbuz; A Semih Dogan
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of B.U.ON. : official journal of the Balkan Union of Oncology     Volume:  14     ISSN:  1107-0625     ISO Abbreviation:  J BUON     Publication Date:    2009 Oct-Dec
Date Detail:
Created Date:  2010-02-11     Completed Date:  2010-03-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883428     Medline TA:  J BUON     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  721-3     Citation Subset:  IM    
Affiliation:
Department of Medical Oncology, Dr. Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey. ahmetknower@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Ascites / drug therapy,  etiology*,  pathology
Doxorubicin / administration & dosage
Female
Humans
Ifosfamide / administration & dosage
Peritoneal Neoplasms / complications*,  diagnosis,  drug therapy
Prognosis
Sarcoma / complications*,  diagnosis,  drug therapy
Soft Tissue Neoplasms / complications*,  diagnosis,  drug therapy
Treatment Outcome
Chemical
Reg. No./Substance:
23214-92-8/Doxorubicin; 3778-73-2/Ifosfamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metastatic melanoma: case report of a patient with seventeen months of complete remission, five year...
Next Document:  Bernard Peyrilhe (1737-1804) and the first experimental transmission of cancer.